{"data":{"id":3402,"citation":"Lounsbury N, Mateo G, Jones B, Papaiahgari S, Thimmulappa RK, Teijaro C, Gordon J, Korzekwa K, Ye M, Allaway G, Abou-Gharbia M, Biswal S, Childers W.: Heterocyclic chalcone activators of nuclear factor (erythroid-derived 2)-like 2 (Nrf2) with improved in vivo efficacy. Bioorg Med Chem, Volume 23 (17), 2015","title":"Heterocyclic chalcone activators of nuclear factor (erythroid-derived 2)-like 2 (Nrf2) with improved in vivo efficacy.","doi":"10.1016\/j.bmc.2015.07.056","doi_url":"https:\/\/doi.org\/10.1016\/j.bmc.2015.07.056","pmid":"26278028","pmid_url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/26278028\/","year":2015,"journal":"Bioorg Med Chem","volume":"23","issue":"17","page":"5352-5359","authors":[{"first_name":"Abou-Gharbia M","last_name":null,"full_name":null},{"first_name":"Allaway G","last_name":null,"full_name":null},{"first_name":"Biswal S","last_name":null,"full_name":null},{"first_name":"Childers W.","last_name":null,"full_name":null},{"first_name":"Gordon J","last_name":null,"full_name":null},{"first_name":"Jones B","last_name":null,"full_name":null},{"first_name":"Korzekwa K","last_name":null,"full_name":null},{"first_name":"Lounsbury N","last_name":null,"full_name":null},{"first_name":"Mateo G","last_name":null,"full_name":null},{"first_name":"Papaiahgari S","last_name":null,"full_name":null},{"first_name":"Teijaro C","last_name":null,"full_name":null},{"first_name":"Thimmulappa RK","last_name":null,"full_name":null},{"first_name":"Ye M","last_name":null,"full_name":null}],"url":"https:\/\/molmedb.upol.cz\/api\/v1\/publications\/3402","landing_page":"https:\/\/molmedb.upol.cz\/publication\/3402","created_at":"2024-05-21T20:11:57.000000Z","updated_at":null}}